Venture&Growth
Location
Wayne (PA), USA
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
US-based MedTech company developing a novel venous stent.
Vesper Medical is a medical device company dedicated to the development of a novel venous stent for the treatment of a variety of venous diseases. The company had achieved CE Mark and has initiated the VIVID trial in the US for FDA approval. Vesper was founded in 2016 as a spin-out of Intact Vascular.
In 2022, Royal Philips acquired 100% of the Vesper shares, providing Gilde with an attractive return within a three-year holding period.
More Vesper Medical news
Vesper Medical Announces First Enrollment in the VIVID Trial
Gilde Healthcare co-leads $37M financing of Vesper Medical to complete development of its Duo Venous Stent System
Big Health
UK-based digital therapy company focused on mental disorders.
Noema Pharma
Swiss Therapeutics company developing therapies to treat severe neurological disorders.
Sanifit
Spanish Therapeutics company developing treatment of vascular calcification disorders of kidney patients.
